The challenging funding environment will likely prompt small- and mid-cap listed life sciences companies to seek financing through private investments in public equity.
Small- and mid-cap life sciences companies typically...more
7/28/2023
/ Capital Raising ,
Convertible Notes ,
Corporate Financing ,
EU ,
Financing ,
Investors ,
Life Sciences ,
PIPEs ,
Private Investment Funds ,
Small and Medium-Sized Enterprises (SMEs) ,
Strategic Planning